ATRX and gastric cancer: Ge et al. explored sex variance in GC somatic mutation profiles and observed that ATRX (tumor gene suppressor involved in DNA damage repair) mutations occurred more frequently in female GC and correlated to the MSI-high subtype, better overall survival, and favorable clinical benefit to ICI in patients with GC [62].